AstraZeneca’s Imfinzi Receives FDA Priority Review for Small Cell Lung Cancer
On Thursday, AstraZeneca (NASDAQ: AZN) said the U.S. Food and Drug Administration (FDA) has granted its blockbuster cancer drug Imfinzi […]
AstraZeneca’s Imfinzi Receives FDA Priority Review for Small Cell Lung Cancer Read More »
